Abstract
Polo-like kinase 1 (Plk1) overexpression is associated with tumorigenesis by an unknown mechanism. Likewise, Plk1 was suggested to act as a negative regulator of tumor suppressor p53, but the mechanism remains to be determined. Herein, we have identified topoisomerase I-binding protein (Topors), a p53-binding protein, as a Plk1 target. We show that Plk1 phosphorylates Topors on Ser718 in vivo. Significantly, expression of a Plk1-unphosphorylatable Topors mutant (S718A) leads to a dramatic accumulation of p53 through inhibition of p53 degradation. Topors is an ubiquitin and small ubiquitin-like modifier ubiquitin-protein isopeptide ligase (SUMO E3) ligase. Plk1-mediated phosphorylation of Topors inhibits Topors-mediated sumoylation of p53, whereas p53 ubiquitination is enhanced, leading to p53 degradation. These results demonstrate that Plk1 modulates Topors activity in suppressing p53 function and identify a likely mechanism for the tumorigenic potential of Plk1. © 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Yang, X., Li, H., Zhou, Z., Wang, W. H., Deng, A., Andrisani, O., & Liu, X. (2009). Plk1-mediated phosphorylation of topors regulates p53 stability. Journal of Biological Chemistry, 284(28), 18588–18592. https://doi.org/10.1074/jbc.C109.001560
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.